CNE100005XY6
CNE100005XY6
CHANGCHUN BCHT BIOTECHNOLOGY CO
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 7.36B EUR | 5.77B EUR | 7.31B EUR | 7.8B EUR |
Enterprise Value | 7.55B EUR | 5.95B EUR | 7.43B EUR | 7.87B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 11.78x | 13.25x | 18.24x | 18.78x |
Price to Book | 1.94x | 1.52x | 1.9x | 2.03x |
EV/Revenue | 12.08x | 13.68x | 18.54x | 18.93x |
EV/EBITDA | -61.41x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | 240.47x | -- |
EV/FCF | -- | -- | 244.52x | -- |
FCF Yield | -3.49% | -0.15% | 0.42% | -0.7% |